loading

Kalvista Pharmaceuticals Inc Aktie (KALV) Neueste Nachrichten

pulisher
10:33 AM

Pharvaris Surges, Pulling KalVista Out Of A Slump, On Promising New HAE Treatment - MSN

10:33 AM
pulisher
05:13 AM

Why pension funds invest in KalVista Pharmaceuticals Inc. (4XC1) stockWeekly Profit Analysis & High Conviction Buy Zone Alerts - Newser

05:13 AM
pulisher
01:24 AM

Will KalVista Pharmaceuticals Inc. (4XC1) stock profit from automation waveJuly 2025 Review & Safe Capital Investment Plans - Newser

01:24 AM
pulisher
Dec 02, 2025

How KalVista Pharmaceuticals Inc. stock reacts to inflationary pressures2025 EndofYear Setup & Free High Return Stock Watch Alerts - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Is KalVista Pharmaceuticals Inc. stock a contrarian buyJuly 2025 Price Swings & Verified Momentum Stock Alerts - Newser

Dec 02, 2025
pulisher
Nov 29, 2025

Behavioral Patterns of KALV and Institutional Flows - news.stocktradersdaily.com

Nov 29, 2025
pulisher
Nov 27, 2025

KalVista Pharma CMO Audhya sells $71k in stock By Investing.com - Investing.com South Africa

Nov 27, 2025
pulisher
Nov 27, 2025

KalVista Pharmaceuticals Stock (KALV) Opinions on Q3 Revenue Success - Quiver Quantitative

Nov 27, 2025
pulisher
Nov 27, 2025

KALV SEC FilingsKalvista Pharm 10-K, 10-Q, 8-K Forms - Stock Titan

Nov 27, 2025
pulisher
Nov 27, 2025

KalVista Pharma CFO Piekos sells $60k in shares By Investing.com - Investing.com Canada

Nov 27, 2025
pulisher
Nov 26, 2025

KalVista Pharma exec Yea sells $58k in shares By Investing.com - Investing.com Nigeria

Nov 26, 2025
pulisher
Nov 26, 2025

KalVista Pharma CMO Audhya sells $71k in stock - Investing.com

Nov 26, 2025
pulisher
Nov 26, 2025

KalVista Pharma exec Yea sells $58k in shares - Investing.com

Nov 26, 2025
pulisher
Nov 26, 2025

KalVista Pharmaceuticals Executives Sell Shares for Tax Obligations - TradingView

Nov 26, 2025
pulisher
Nov 26, 2025

Officer Audhya Acquires 5,954 Of KalVista Pharmaceuticals Inc [KALV] - TradingView

Nov 26, 2025
pulisher
Nov 24, 2025

KalVista Pharmaceuticals, Inc. (KALV) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 24, 2025
pulisher
Nov 21, 2025

Is KalVista Pharmaceuticals Inc. stock positioned well for digital economyGap Down & High Conviction Buy Zone Picks - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Real time scanner hits for KalVista Pharmaceuticals Inc. explainedQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 19, 2025

Multi asset correlation models including KalVista Pharmaceuticals Inc.July 2025 Trends & Consistent Profit Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What makes KalVista Pharmaceuticals Inc. stock attractive to growth funds2025 Earnings Surprises & Stock Portfolio Risk Control - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will KalVista Pharmaceuticals Inc. (4XC1) stock keep high P E multiplesQuarterly Portfolio Review & Consistent Growth Equity Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Citizens reiterates Market Outperform rating on Kalvista stock at $28 target - Investing.com Canada

Nov 19, 2025
pulisher
Nov 19, 2025

How to manage a losing position in KalVista Pharmaceuticals Inc.Watch List & Fast Gaining Stock Strategy Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What market sentiment indicators show for KalVista Pharmaceuticals Inc. (4XC1) stockQuarterly Investment Review & Low Drawdown Momentum Ideas - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Will KalVista Pharmaceuticals Inc. (4XC1) stock benefit from commodity supercycle2025 Institutional Moves & Real-Time Volume Analysis - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Citizens Touts KalVista Pharmaceuticals, Inc. (KALV) Growth Trajectory on EKTERLY Prospects - Insider Monkey

Nov 18, 2025
pulisher
Nov 17, 2025

10 Best Breakout Stocks to Invest In - Insider Monkey

Nov 17, 2025
pulisher
Nov 16, 2025

KalVista Pharmaceuticals, Inc. (KALV) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 16, 2025
pulisher
Nov 15, 2025

How KalVista Pharmaceuticals Inc. stock performs in high volatility marketsEarnings Recap Report & AI Based Buy and Sell Signals - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

How hedge fund analytics apply to KalVista Pharmaceuticals Inc. stockJuly 2025 Review & Reliable Momentum Entry Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

How strong is KalVista Pharmaceuticals Inc. (4XC1) stock earnings growthAnalyst Upgrade & Safe Entry Zone Tips - newser.com

Nov 15, 2025
$39.95
price up icon 1.06%
$101.08
price down icon 0.43%
$31.62
price down icon 0.30%
$96.26
price up icon 0.18%
biotechnology ONC
$331.38
price up icon 0.36%
$206.48
price down icon 0.04%
Kapitalisierung:     |  Volumen (24h):